News

Cancellation of the Forum of the EU Mission on Adaptation to Climate Change

Published on | 1 hour ago

Programmes
Climate, Energy, Mobility Missions

After careful consideration of the evolving circumstances in the Middle East, The European Commission (EC) has taken the decision to cancel the Forum of the EU Mission on Adaptation to Climate Change planned in Cyprus this May.  

This reflects both the increasing uncertainty surrounding travel and participation, as well as the desire to ensure the event can take place under conditions that allow for broad representation and inclusive engagement. 

The EC is currently exploring the possibility of hosting the Fifth Mission Forum at an alternative location in the Autumn of this year. Further information will follow in due course.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1835 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.